Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

PubWeight™: 9.05‹?› | Rank: Top 0.1%

🔗 View Article (PMID 17919504)

Published in Gastroenterology on August 08, 2007

Authors

Glenn T Furuta1, Chris A Liacouras, Margaret H Collins, Sandeep K Gupta, Chris Justinich, Phil E Putnam, Peter Bonis, Eric Hassall, Alex Straumann, Marc E Rothenberg, First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees

Author Affiliations

1: Section of Pediatric Gastroenterology, Hepatology, and Nutrition, The Children's Hospital, Denver, University of Colorado Medical School, Denver, Colorado, USA.

Associated clinical trials:

Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index (EEsAI) | NCT00939263

Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders | NCT01212016

A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children | NCT01458418

EoE Food Desensitization | NCT02881372

Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation | NCT00667524

Metabolomics for Biomarker Discovery in Children With EoE | NCT03107819

Articles citing this

(truncated to the top 100)

Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55

Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2012) 3.45

Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis. Am J Gastroenterol (2012) 2.70

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55

Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53

Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol (2011) 2.47

Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet (2010) 2.47

A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc (2013) 2.34

Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol (2013) 2.25

Biology and treatment of eosinophilic esophagitis. Gastroenterology (2009) 2.18

The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther (2015) 2.16

Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol (2008) 2.12

Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology (2010) 2.10

Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol (2010) 2.00

Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut (2012) 2.00

The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut (2012) 1.98

Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96

Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci (2009) 1.91

Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 1.90

Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients. Clin Gastroenterol Hepatol (2014) 1.87

Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol (2010) 1.85

A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2009) 1.85

A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82

Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2013) 1.75

Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75

Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.74

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71

Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci (2009) 1.70

Outcomes of children after esophagogastroduodenoscopy for chronic abdominal pain. Clin Gastroenterol Hepatol (2013) 1.69

A Japanese case series of 12 patients with esophageal eosinophilia. J Gastroenterol (2010) 1.66

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis. Gastroenterology (2012) 1.65

Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy (2009) 1.64

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64

Eosinophilic gastroenteritis: a review. J Gastroenterol (2008) 1.63

Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63

Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Am J Gastroenterol (2016) 1.61

Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology (2013) 1.51

Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am (2009) 1.51

Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment. J Allergy Clin Immunol (2012) 1.50

Esophageal foreign-body impactions: epidemiology, time trends, and the impact of the increasing prevalence of eosinophilic esophagitis. Gastrointest Endosc (2011) 1.49

Advances in clinical management of eosinophilic esophagitis. Gastroenterology (2014) 1.48

Guidelines for the use and interpretation of diagnostic methods in adult food allergy. Clin Mol Allergy (2015) 1.47

Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 1.46

The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther (2013) 1.45

Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2009) 1.44

Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One (2012) 1.43

Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis. Dig Dis Sci (2011) 1.43

Eosinophilic esophagitis. Dig Dis Sci (2009) 1.43

IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol (2010) 1.41

Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease. Am J Gastroenterol (2010) 1.37

Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2014) 1.34

Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology (2011) 1.29

Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol (2012) 1.28

Comparison of esomeprazole to aerosolized, swallowed fluticasone for eosinophilic esophagitis. Dig Dis Sci (2009) 1.26

Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. J Allergy Clin Immunol (2010) 1.25

Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology (2014) 1.23

Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol (2014) 1.22

Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol (2011) 1.22

Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol (2009) 1.21

Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol (2011) 1.20

Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.20

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion (2009) 1.19

Epidemiology and management of oesophageal coin impaction in children. Dig Liver Dis (2012) 1.18

Eosinophilic colitis: epidemiology, clinical features, and current management. Therap Adv Gastroenterol (2011) 1.15

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut (2015) 1.13

Longitudinal muscle dysfunction in achalasia esophagus and its relevance. J Neurogastroenterol Motil (2013) 1.12

Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol (2012) 1.12

Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol (2013) 1.11

Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology (2015) 1.11

Eosinophilic esophagitis. World J Gastroenterol (2009) 1.09

Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: a review of the literature. World J Gastroenterol (2008) 1.09

Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol (2008) 1.09

Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. World J Gastroenterol (2012) 1.09

Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: Implications for endoscopic biopsy. J Allergy Clin Immunol (2012) 1.09

Esophageal functional impairments in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.09

Eosinophilic esophagitis: the newest esophageal inflammatory disease. Nat Rev Gastroenterol Hepatol (2009) 1.09

Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol (2011) 1.08

Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol (2014) 1.07

Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol (2010) 1.06

Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol (2009) 1.06

Manometric features of eosinophilic esophagitis in esophageal pressure topography. Neurogastroenterol Motil (2010) 1.05

Practice patterns for the evaluation and treatment of eosinophilic oesophagitis. Aliment Pharmacol Ther (2010) 1.05

Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol (2010) 1.05

A Clinical Prediction Tool Identifies Cases of Eosinophilic Esophagitis Without Endoscopic Biopsy: A Prospective Study. Am J Gastroenterol (2015) 1.04

GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun (2014) 1.02

PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity. J Pediatr Gastroenterol Nutr (2013) 1.02

FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis. Gut (2008) 1.01

Administrative coding is specific, but not sensitive, for identifying eosinophilic esophagitis. Dis Esophagus (2013) 1.01

The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc (2015) 1.01

Fluticasone and food allergen elimination reverse sub-epithelial fibrosis in children with eosinophilic esophagitis. Dig Dis Sci (2010) 1.00

Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am J Pathol (2011) 1.00

Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study. Am J Gastroenterol (2015) 1.00

Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol (2009) 1.00

Effect of proton pump inhibitor on esophageal eosinophilia. J Pediatr Gastroenterol Nutr (2013) 1.00

Causes of esophageal food bolus impaction in the pediatric population. Dig Dis Sci (2011) 0.99

Strategy for treatment of nonerosive reflux disease in Asia. World J Gastroenterol (2008) 0.99

Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child Care Health Dev (2011) 0.98

Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens. Gastrointest Endosc (2011) 0.98

Clinical characteristics and sensitivity to food and inhalants among children with eosinophilic esophagitis. BMC Res Notes (2014) 0.98

Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol (2012) 0.98

Articles by these authors

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol (2013) 5.09

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 4.93

Eosinophilic esophagitis. N Engl J Med (2004) 4.43

Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology (2013) 4.20

Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08

Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68

Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr (2009) 3.66

Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol (2005) 3.53

Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol (2006) 3.51

Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2012) 3.45

IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol (2007) 3.24

Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol (2005) 3.13

Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol (2003) 3.05

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04

MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89

Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr (2008) 2.82

Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74

Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet (2010) 2.47

The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol (2002) 2.43

Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology (2003) 2.40

CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39

14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr (2009) 2.36

Foxa2 regulates alveolarization and goblet cell hyperplasia. Development (2004) 2.35

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol (2003) 2.31

Safety of intravenous midazolam and fentanyl for pediatric GI endoscopy: prospective study of 1578 endoscopies. Gastrointest Endosc (2007) 2.22

IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol (2008) 2.19

Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol (2007) 2.18

Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest (2003) 2.17

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol (2009) 2.16

Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol (2012) 2.13

Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol (2008) 2.12

Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol (2011) 2.07

IL-5 promotes eosinophil trafficking to the esophagus. J Immunol (2002) 2.06

Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol (2003) 2.06

Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol (2013) 2.05

Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol (2008) 2.04

Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04

Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol (2010) 2.00

MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol (2011) 2.00

Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med (2009) 1.97

Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92

A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol (2009) 1.89

Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol (2004) 1.87

Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86

Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer (2003) 1.86

Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol (2010) 1.85

Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol (2007) 1.85

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2006) 1.84

A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82

Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol (2002) 1.82

Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2011) 1.82

Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol (2005) 1.80

Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol (2006) 1.79

A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2008) 1.79

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol (2012) 1.79

Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology (2005) 1.78

Prevalence and outcome of allergic colitis in healthy infants with rectal bleeding: a prospective cohort study. J Pediatr Gastroenterol Nutr (2005) 1.78

Biology of the eosinophil. Adv Immunol (2009) 1.74

Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.74

The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol (2005) 1.73

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology (2011) 1.67

Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol (2010) 1.67

Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis (2009) 1.65

Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63

Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol (2007) 1.61

MiR-223 deficiency increases eosinophil progenitor proliferation. J Immunol (2013) 1.60

Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet (2013) 1.60

Eosinophilic esophagitis: pathogenesis, genetics, and therapy. J Allergy Clin Immunol (2006) 1.60

A negative, double-blind, placebo-controlled challenge to genetically modified corn. J Allergy Clin Immunol (2003) 1.57

Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol (2009) 1.56

Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol (2006) 1.56